ストックスクリーナーアプリを入手
9.49
1.35%
-0.13
アフターアワーズ：
9.49
Neogenomics Inc (NEO) 最新ニュース
Benchmark maintains Hold on Neogenomics stock, reiterates price target By Investing.com - Investing.com UK
Where are the Opportunities in (NEO) - news.stocktradersdaily.com
3 Reasons to Sell NEO and 1 Stock to Buy Instead - Yahoo Finance
Piper Sandler maintains Neogenomics stock with $18 target - Investing.com
Piper Sandler maintains Neogenomics stock with $18 target By Investing.com - Investing.com UK
NeoGenomics elevates Warren Stone to President and COO By Investing.com - Investing.com Australia
NeoGenomics Promotes Warren Stone to President & COO - TipRanks
Fort Myers-based NeoGenomics names new COO - Gulfshore Business
Earnings call transcript: NeoGenomics Q4 2024 results disappoint despite EPS beat - Investing.com
NeoGenomics elevates Warren Stone to President and COO - Investing.com
NeoGenomics Names Warren Stone President, COO -March 18, 2025 at 08:09 am EDT - Marketscreener.com
NeoGenomics Appoints Warren Stone as President & Chief Operating Officer - Lelezard
NeoGenomics Appoints Warren Stone As President & Chief Operating Officer -March 18, 2025 at 07:10 am EDT - Marketscreener.com
Commit To Buy NeoGenomics At $8, Earn 19.6% Annualized Using Options - Nasdaq
NeoGenomics (NASDAQ:NEO) Stock Price Up 7.2%Here's What Happened - MarketBeat
SBI Securities Co. Ltd. Invests $26,000 in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics at Barclays Healthcare: Strategic Focus on Innovation - Investing.com India
Bank of New York Mellon Corp Purchases 15,269 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics, Inc. (NASDAQ:NEO) Receives $19.60 Average Target Price from Analysts - Defense World
NeoGenomics at Leerink Global Healthcare: Strategic Transition and Growth By Investing.com - Investing.com South Africa
(NEO) Technical Pivots with Risk Controls - news.stocktradersdaily.com
NeoGenomics at Leerink Global Healthcare: Strategic Transition and Growth - Investing.com
Fort Myers-based NeoGenomics expands cancer testing reach with acquisition - News-Press
Proficio Capital Partners LLC Invests $372,000 in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
BTIG maintains $17 target on Neogenomics stock post-acquisition By Investing.com - Investing.com UK
NeoGenomics Acquires Pathline -March 10, 2025 at 08:13 am EDT - Marketscreener.com
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline - BioSpace
NeoGenomics expands with Pathline acquisition - Investing.com India
NeoGenomics expands with Pathline acquisition By Investing.com - Investing.com South Africa
NeoGenomics Expands Oncology Testing Reach In The Northeast With Acquisition Of Pathline - Marketscreener.com
Smartleaf Asset Management LLC Has $70,000 Position in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R) - ACCESS Newswire
NeoGenomics, Inc.'s (NASDAQ:NEO) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors - Simply Wall St
NeoGenomics, Inc. to Host Earnings Call - ACCESS Newswire
NeoGenomics price target lowered to $17 from $18 at BTIG - MSN
NeoGenomics at TD Cowen Conference: CEO Transition and Growth Plans By Investing.com - Investing.com UK
NeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Truist Financial Corp - Defense World
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes - ACCESS Newswire
NeoGenomics Announces Leadership Team Transition - ACCESS Newswire
Investor Network Invites You to the NeoGenomics First Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, April 26, 2017 - ACCESS Newswire
Principal Financial Group Inc. Acquires 18,455 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics (NASDAQ:NEO) Sets New 52-Week LowTime to Sell? - MarketBeat
NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference - ACCESS Newswire
NeoGenomics To Virtually Participate In Fireside Chat At The Stephens Annual Investment Conference 2020 - ACCESS Newswire
NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference - ACCESS Newswire
NeoGenomics Schedules its Second Quarter Earnings Release for July 30, 2019 - ACCESS Newswire
NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences - ACCESS Newswire
NeoGenomics to Participate Virtually in Multiple Upcoming Institutional Investor Conferences - ACCESS Newswire
NeoGenomics: Decent Fundamentals, But Still Overvalued - Seeking Alpha
NeoGenomics First to Partner with Biomarker Collaborative and Deliver Patient Resources Along with Oncology Testing Results - ACCESS Newswire
NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter - ACCESS Newswire
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2019 Earnings Release for February 27, 2020 - ACCESS Newswire
NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020 - ACCESS Newswire
NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference - ACCESS Newswire
NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020 - ACCESS Newswire
NeoGenomics to Host Second Quarter 2014 Earnings Webcast Live on Thursday, July 17, 2014 - ACCESS Newswire
Piper Sandler Lowers NeoGenomics (NASDAQ:NEO) Price Target to $18.00 - MarketBeat
NeoGenomics Reports Third Quarter 2023 Results - ACCESS Newswire
1.12%
1.76%
大文字化:
|
ボリューム (24 時間):